Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem useAntibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission ratesBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaAntimicrobial consumption data from pharmacy and nursing records: how good are they?Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceMolecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms.Reversibility of antibiotic resistanceEradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stoneAntibiotic consumption and healthcare-associated infections caused by multidrug-resistant gram-negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship.Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.Emergence of carbapenem resistance due to the novel insertion sequence ISPa8 in Pseudomonas aeruginosaThe role of quorum sensing system in antimicrobial induced ampC expression in Pseudomonas aeruginosa biofilm.Relationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates.Gram-stain-based antimicrobial selection reduces cost and overuse compared with Japanese guidelines.The impact of antibiotic management on resistance.Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique.Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?Carbapenems: a potent class of antibiotics.Asia-Pacific consensus guidelines on gastric cancer prevention.Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications.Correlation between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a medical-surgical intensive care unit.Intra-abdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance.Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis.Pharmacotherapy for hospital-acquired pneumonia.Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.Seasonality of antibiotic prescriptions for outpatients and resistance genes in sewers and wastewater treatment plant outflow.Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008-2014.Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013).Spread of Metallo-β-lactamases: screening reveals the presence of aBLA SPM-1 gene in hospital sewage in southern Brazil.Affinity of Tomopenem (CS-023) for penicillin-binding proteins in Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study.[Determination of associated antimicrobial resistance in clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa in a public hospital in Goiânia, State of Goiás].Susceptibility patterns in Pseudomonas aeruginosa causing nosocomial infections.Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment.Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.Correlation between case mix index and antibiotic use in hospitals.Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.
P2860
Q26739860-05452C4E-8BE4-49F6-83BE-D03EA600F365Q28299749-C228CE32-4E5C-4B18-955B-19BC68A2B4C3Q28536492-A7B65CE2-DEB1-448B-BCD6-18F506B57057Q29616084-36839A4A-2BC8-45D3-A7A3-541ED01F13C4Q30988681-19567975-C58D-413C-B65F-0CB634DE3543Q33640559-1166945F-6E65-4477-8C90-9D46014DEED1Q33648133-60079A7B-5B51-42F4-87DD-6411519181B0Q33667524-79135997-7D08-44E1-9ACE-C5417DA93D69Q34408895-267CB976-8F91-4821-87DB-9F65976E667FQ34759062-3CA245F3-20D5-4CE1-96A3-4877D5C3788BQ34999543-359FA007-B283-46A8-A7B1-732EA6F3CFD7Q35116174-9EBEF9F6-053C-4C45-A3FA-383418F2DA8AQ35223005-F4F6682A-24A9-4599-8D5D-9D11F6EAF3B4Q35230461-DF6B1A14-94B2-4300-A960-4795AA149AE3Q35822009-07522EAA-118D-4CC6-9AA0-FAADE2265274Q35976861-20CEA7E7-1CBC-4B60-B054-F59B9B398011Q36243482-EF43065F-469F-468B-AD0F-95F25182F052Q36757551-DDBDA5C3-FBC7-4FAF-B097-BDE3617346B0Q37030838-04D3C209-3548-41FC-8D82-5C81E7B063DCQ37101686-B1D15FEC-A70A-4DE6-95D8-7776A4A8E0E7Q37291366-8CF1E0A0-D540-4C99-AF21-936A278C2DB1Q37385015-6E784413-FF23-4E33-9F16-9923298B12C6Q37557841-1A755B48-0476-4281-8FB9-FCC43405EC2DQ37993716-9F32F8DC-6BDA-449C-9D53-1FB59718FBA9Q38120490-07D6F760-6675-4D02-9588-7E31790EF267Q38192023-5D1DCCC3-3728-4DE4-B1F4-957469775F9DQ39501803-BD507FC3-D277-4F2F-A9C5-E1D324162F1AQ39854828-37963871-9379-4CC0-8C5F-EC03BD06CF9CQ40305798-B3E85A4B-E401-4984-8B7E-376298FF6784Q41610406-CA09A47C-E0A4-41A3-B361-DBCA88E15D35Q42058360-1386441E-489E-4BEE-8F7A-336399BFA7E7Q42111745-86532BA4-4F47-4675-9CF5-8819150FFC18Q42202436-B4F4BF8C-2B29-4A9B-BA2E-0EE44EEA5077Q43267359-C07BC2F7-751E-408A-BB6E-EE030A71F381Q44066453-237B7416-C42C-42A8-81D6-98E1F5C03D2BQ44440432-5D189702-6E26-44FB-8C78-195839589CCDQ44654345-755AF060-6DCF-4800-8822-179AF99982DAQ44798838-44CD668C-EE18-40DB-B9F8-357FD4E5B0C5Q46906475-54C21875-1766-48DF-92A5-32EEF09E13ECQ47218332-5D87C0CF-523C-4B7F-9C7A-0B58F8BA4A46
P2860
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@ast
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@en
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@nl
type
label
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@ast
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@en
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@nl
prefLabel
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@ast
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@en
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@nl
P2093
P2860
P1476
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa
@en
P2093
Eberhard Grusa
Helga Reichl
Josef Högel
Matthias Trautmann
Philipp M Lepper
P2860
P304
P356
10.1128/AAC.46.9.2920-2925.2002
P407
P577
2002-09-01T00:00:00Z